Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 27, 2026
CMS Energy (CMS): Can This Utility Stock Rebound to $80?

CMS Energy (CMS): Can This Utility Stock Rebound to $80?

Key Takeaways

  • After reaching a 52-week high near $80 earlier this year, CMS shares have retreated and recently traded near $63, close to the bottom of their 52-week range.
  • The main bullish drivers include Michigan’s favorable regulatory setting, rising electricity demand from data centers, and a solid history of dividend increases.
  • Higher interest rates, a premium valuation, weaker recent earnings, and several analyst downgrades represent the primary hurdles to a return toward $80.
  • Analyst price targets generally cluster around $78–$80, so that level remains a plausible though not assured goal.
  • Near-term support is around the $62 zone (the 52-week low), while resistance appears near $70 and $75 ahead of the $80 target.

Why the $80 Level Stands Out

CMS Energy Corporation (NYSE: CMS) is a Jackson, Michigan-based utility whose main operations run through Consumers Energy, serving much of Michigan’s Lower Peninsula with regulated electric and natural gas service. The $80 mark has drawn attention because the stock touched roughly that price within the past year before pulling back, leaving it well below the prior peak. Since $80 also lines up closely with the consensus analyst target and carries psychological weight as a round number, investors are naturally focused on whether the shares can sustain a recovery from near their 52-week low.

Current Market Position

The decline in CMS has been notable for a typically defensive utility name. After trading in the mid-$70s earlier in 2026, shares softened through the summer and fall, recently changing hands near $63 — not far from the low end of a 52-week range spanning roughly $62 to $80. The move reflects both company-specific factors and broader pressure on dividend-paying stocks. CMS reported softer second-quarter earnings and announced it would exit non-utility renewable development to focus capital on its regulated operations. While that shift is viewed as supportive for long-term earnings quality, it added short-term uncertainty. At the same time, rising Treasury yields weighed on the broader utilities sector.

Factors That Could Support a Recovery

Several elements point to a longer-term rebound. The core regulated business remains sound, operating in a constructive Michigan regulatory environment that offers visibility on rate-based revenue and cost recovery. Management continues to guide for 6% to 8% long-term adjusted EPS growth, and the company has raised its dividend for 17 straight years while maintaining an investment-grade credit rating. Growing electricity demand tied to data centers and electrification is also improving load growth in Michigan, which should benefit utilities with visible capital programs. The valuation reset itself may open room for upside, as the stock sits near its 52-week low while consensus targets remain in the high $70s to low $80s.

Obstacles That Could Limit Upside

Challenges remain equally clear. Even after the pullback, CMS trades at a premium to the average integrated utility, with a P/E multiple in the low-20s versus a peer average closer to the high-teens. That leaves little margin if growth slows or if interest rates stay elevated. Sentiment has softened as well: Jefferies downgraded the stock to Hold in mid-2026, KeyBanc moved to Sector Weight, and several firms trimmed targets in August and September. Reclaiming $80 would likely require steady execution, a more favorable rate environment, and renewed conviction that earnings growth justifies the valuation.

Analyst Price Targets

The overall Street view stays constructive but has eased. Consensus ratings sit around “Moderate Buy,” with an average 12-month target in the high $70s to low $80s — essentially aligned with the $80 level under discussion. The highest targets reach the mid-to-high $80s, while the lowest sit near the high $60s. The spread reflects differing views on how much of the company’s growth and regulatory advantages are already priced in.

Technical Levels Worth Monitoring

From a technical standpoint, the picture is straightforward. The $62 area — the 52-week low — is the key near-term support; a break below it would point to further downside. On the upside, resistance layers at the $70 round number and the mid-$70s, with $80 serving as both the prior high and the main psychological target. A sustained move toward $80 would first require reclaiming and holding the mid-$70s to turn prior resistance into support. I also checked this setup using Tickeron’s AI Screener to see how CMS compares with peers.

Using AI Daily Buy/Sell Signals for Monitoring

When tracking setups like the one in CMS, I find Tickeron’s AI Daily Buy/Sell Signals helpful for staying on top of shifting conditions. The tool applies artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on market changes, technical behavior, and AI analysis. It has become a practical part of my routine for spotting opportunities, reviewing positions, and catching evolving trends without having to sift through everything manually.

Final Assessment

Can CMS Energy realistically return to $80? The level sits squarely inside the analyst consensus range and matches the stock’s prior 52-week high, so it is not an unrealistic objective. The regulated business, supportive Michigan regulation, improving load growth, and 17-year dividend streak provide a credible base. Still, the path is not guaranteed. A premium valuation, elevated rates, softer recent earnings, and analyst downgrades all stand in the way. Reaching $80 would probably need stabilizing yields, clean execution on the regulated-growth plan, and a re-rating that does not yet look assured. Investors should keep an eye on earnings delivery, interest-rate trends, and whether the stock can hold $62 support while reclaiming the mid-$70s.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CMS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CMS sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for CMS moved below the 200-day moving average on August 31, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CMS as a result. In 33 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 37%.

The Moving Average Convergence Divergence Histogram (MACD) for CMS turned negative on September 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 27 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.

The Aroon Indicator for CMS entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where CMS advanced for three days, in 167 of 346 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.

CMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.067) is normal, around the industry mean (1.685). P/E Ratio (18.933) is within average values for comparable stocks, (16.793). Projected Growth (PEG Ratio) (2.269) is also within normal values, averaging (1.932). Dividend Yield (0.036) settles around the average of (0.036) among similar stocks. P/S Ratio (2.291) is also within normal values, averaging (85.686).

The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. CMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock worse than average.

Notable companies

The most notable companies in this group are Nextera Energy Inc (NYSE:NEE), Southern Company (The) (NYSE:SO), Dominion Energy (NYSE:D), PG&E Corp (NYSE:PCG).

Industry description

Electric utilities companies generate, transmit and distribute electricity to businesses/offices and residences. Companies may be owned by the government or investors or public shareholders, or a combination thereof. The industry also includes firms that buy and sell electricity. Companies in this industry typically require significant investments in infrastructure. Many firms in this industry pay substantial and regular dividends to shareholders. However, changes in interest rates (and their impact on debt burdens), natural disasters and changing commodity prices could be factors affecting energy utilities’ profit margins. NextEra Energy, Inc., Duke Energy Corporation, Dominion Energy Inc. and Southern Company are among U.S. electric utilities companies with the largest market capitalizations.

Market Cap

The average market capitalization across the Electric Utilities Industry is 28.25B. The market cap for tickers in the group ranges from 300 to 158.7B. NEE holds the highest valuation in this group at 158.7B. The lowest valued company is SLTZ at 300.

High and low price notable news

The average weekly price growth across all stocks in the Electric Utilities Industry was -3%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -10%. IMSR experienced the highest price growth at 3%, while NKLR experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Electric Utilities Industry was -38%. For the same stocks of the Industry, the average monthly volume growth was 53% and the average quarterly volume growth was 16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 37
P/E Growth Rating: 55
Price Growth Rating: 61
SMR Rating: 69
Profit Risk Rating: 58
Seasonality Score: -51 (-100 ... +100)
View a ticker or compare two or three
CMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of electric and gas utility services

Industry ElectricUtilities

Industry
Electric Utilities
Address
One Energy Plaza
Phone
+1 517 788-0550
Employees
8350
Web
https://www.cmsenergy.com
Interact to see
Advertisement
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Shares of GSAT are surging approximately +15% intraday on March 25, 2026, following a prior session close of $61.09. The primary catalyst is a fresh analyst note from Scotiabank highlighting Globalstar's direct-to-device satellite connectivity bypassing cellular towers — most notably in Mexico — reinforcing the company's next-generation infrastructure thesis.
Shares of ADMA are declining approximately 12% in Wednesday's session, extending a steep two-day selloff. The primary catalyst is a short-seller research report published by Culper Research on March 24, 2026, alleging that ADMA engaged in channel stuffing to artificially inflate revenue growth.
Honeywell International (HON) and TransDigm Group (TDG) are prominent players in the aerospace and industrials sector, benefiting from rising air travel demand, defense spending, and aftermarket services. This stock comparison evaluates their business models, recent performance, and market positioning to help traders and investors assess relative strengths in the current environment. With global aviation recovery and geopolitical tensions supporting sector tailwinds, professionals seeking exposure to aerospace growth versus diversified industrials stability will find these insights relevant for portfolio decisions and relative performance analysis.
PL shares are surging approximately +15% in Wednesday's session, trading near $35.89, pushing back toward the stock's 52-week high of $36.28 set on March 20, 2026. Primary catalyst: Continued momentum from a blockbuster Q4 fiscal 2026 earnings report delivered March 19, which sent revenue 41% higher year-over-year to $86.8 million, well above the $78 million Wall Street consensus.
ASTS shares surged approximately +11.00% in active intraday trading on March 25, 2026, moving from a prior close of $86.98 to approximately $96.55. The primary driver is a broad space sector rally fueled by renewed SpaceX IPO speculation, lifting satellite and space-related equities across the board.
FUBO shares are set to open about 12% lower in Wednesday’s premarket session after closing the prior day at roughly $12.02. The decline follows a strong multi-week rally powered by balance-sheet news, including the repurchase of $140.2 million of 2026 convertible notes and improving profitability trends.
One & One Green Technologies Inc. (YDDL) shares are indicated down about 13% in Wednesday’s premarket session after closing the prior regular session at $12.00. The stock had just surged 15.6% in the latest completed session, jumping from a prior close of $10.38 to $12.00, leaving it vulnerable to swift profit‑taking and volatility.
AVXL shares are indicated down about 33% in Wednesday’s premarket session, after closing the prior regular session at $4.19. The slide follows a recent drop triggered by a wider‑than‑expected fourth‑quarter loss and ongoing questions about the company’s late‑stage neurology pipeline.